Table 5.

Secondary aims.

Events	Rivaroxaban	Warfarin	p value
	(N = 147)	(N = 153)
Major bleeding other than GI bleeding	6 (4.08%)	4 (2.61%)	0.5348
ICH	1 (0.68%)	0 (0%)	0.4900
Stroke or TIA	1 (0.68%)	1 (0.65%)	1.0000
Symptomatic VTE	2 (1.36%)	2 (1.31%)	1.0000
ACS that required interventions	3 (2.04%)	8 (5.23%)	0.2189
All-cause death	2 (1.36%)	8 (5.23%)	0.1042

ACS: acute coronary syndrome, ICH: intracranial hemorrhage, TIA: transient ischemic attack, and VTE: venous thromboembolism events.